Skip to main content

Table 5 PCR uncorrected adequate clinical and parasitological response (ACPR) at day 42 (intention to treat population)

From: Efficacy and safety of fixed dose combination of arterolane maleate and piperaquine phosphate dispersible tablets in paediatric patients with acute uncomplicated Plasmodium falciparum malaria: a phase II, multicentric, open-label study

 

Arterolane maleate and piperaquine phosphate

95 % CI

Overall Age (6 months to ≤12years) (n = 141)

 Success, n (%)

124 (87.9)

(81.40, 92.82)

Age group 1 (6 months to <2years) (n = 22)

 Success, n (%)

19 (86.4)

(65.09, 97.09)

Age group 2 (2 to <6years) (n = 49)

 Success, n (%)

42 (85.7)

(72.76, 94.06)

Age group 3 (6 to ≤12 years) (n = 70)

 Success, n (%)

63 (90.0)

(80.48, 95.88)